GS consortium’s Hugel acquisition is close to completion Source says price adjustment is unlikely and deal will close soon
Translated by Ryu Ho-joung 공개 2022-01-20 08:12:34
이 기사는 2022년 01월 20일 08:08 thebell 에 표출된 기사입니다.
An acquisition of South Korea’s No. 1 botox maker Hugel by a consortium led by GS Group appears close to completion with no changes to the original agreement.The GS-led consortium signed a share purchase agreement to buy a controlling stake in Hugel from US buyout firm Bain Capital last summer. The transaction has not closed yet, although the deadline for the deal was January 11.
This raised speculation about potential renegotiations over a price, especially after the country’s food and drug agency ordered last November the revocation of licenses for some of the company’s botox products.
However, it appears that the GS consortium remains committed to acquiring Hugel regardless of the revocation issue.
“(The consortium) will pay the remaining acquisition costs soon,” said a source familiar with the deal. “Speculation about a potential price adjustment is not true and that’s highly unlikely.”
The GS consortium agreed to buy a 42.9% stake in Hugel for about 1.7 trillion won ($1.4 billion) in August last year. Around 1.3 trillion won of the total acquisition costs was already paid, while the balance remains to be paid.
The consortium consists of GS Group, Seoul-based private equity firm IMM Investment, Singapore-based healthcare-dedicated investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala.
The consortium funded about 40% of the acquisition costs, or $575 million, through debt financing. Additionally, GS Group plans to pay $150 million by using its cash on hand, while IMM Investment will invest $150 million from its blind-pool fund. (Reporting by Ha-na Suh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [현장 인 스토리]에이루트에코, 서산서 리사이클링 신사업 닻 올렸다
- 더테크놀로지 '리버스삼국' 구글 마켓 인기 1위 달성
- [Red & Blue]'구리 가격' 폭등에 KBI메탈 수혜주 부각
- ‘리딩뱅크’ 신한은행, 정상혁 행장의 조직 대수술 성과 조기도출
- 현대백화점 만기채 상환…금융비용 감축 나섰나
- [IB 풍향계]미래에셋, 중소형 스팩 '심기일전'…빨라진 상장 시계
- [IPO 모니터]'첩첩산중' 노브랜드, 믿을 건 공모 규모뿐
- 미래에셋증권, 펀드 수탁 잭팟…4개월만에 1조 돌파
- 호텔롯데, 1조 기관주문 확보 '달라진 위상'
- [IPO 블루프린트 체크]뉴로메카, 적자 탓 투자 지연…매출 목표 달성 '글쎄'